Autres langues Vivos Therapeutics, Inc.

Actions

VVOS

US92859E2072

Equipement, fournitures et distribution médicale

Temps réel estimé Cboe BZX 18:55:36 08/10/2026			Varia. 5j.	Varia. 1 janv.
0,1480 ^USD	-1,99%		-0,20%	-92,67%

28/08	Vivos Therapeutics, Inc. et South Palm Cardiovascular Associates, Llc signent des accords définitifs pour le lancement d'un centre régional de dépistage et de traitement du sommeil	CI
20/08	Vivos Therapeutics ouvre un centre de traitement du sommeil dans le Nevada	MT

Autres langues

29/09	Vivos Therapeutics Reports Progress in Material Cost Reductions and Revenue Growth Initiatives
29/09	Vivos Therapeutics Reports Progress in Material Cost Reductions and Revenue Growth Initiatives
08/09	Vivos Therapeutics Announces Material Debt Reduction
01/09	Vivos Therapeutics to Present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference
28/08	Vivos Therapeutics, Inc. and South Palm Cardiovascular Associates, Llc Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center
28/08	Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center
25/08	Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers
20/08	Vivos Therapeutics Opens Nevada Sleep Treatment Center
20/08	Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment
20/08	Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada
17/08	Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call
14/08	Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update
14/08	Vivos Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
14/08	Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call
11/08	Vivos Therapeutics Expands Greenway Health Partnership to Deploy AI-Enabled Platform Across All Clinical and Revenue Operations
05/08	Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology
05/08	Top Premarket Decliners
03/08	Vivos Therapeutics, Inc. Announces CFO Changes, Effective July 31, 2026
03/08	Vivos Therapeutics, Inc. Announces Management Changes, Effective July 31, 2026
30/06	Vivos Therapeutics Reports Statistically Significant Improvement In Insomnia Severity With Vida Appliance In Clinical Study
30/06	Vivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants
30/06	Vivos Therapeutics, Inc. announced that it has received $1 million in funding
22/06	Vivos Therapeutics Extends Financing Agreement With Streeterville Through August
22/06	Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity
16/06	Vivos Therapeutics, Inc. and South Palm Cardiovascular Associates, Llc Enter Collaboration Agreement to Form Aim Florida, Llc